<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang X</submitter><funding>National Natural Science Foundation of China</funding><pagination>625492</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7820765</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cryptophthalmos is characterized by congenital ocular dysplasia with eyelid malformation. The pathogenicity of mutations in genes encoding components of the FRAS1/FREM protein complex is well established, but the underlying pathomechanisms of this disease are still unclear. In the previous study, we generated mice carrying &lt;i>Frem2&lt;/i> &lt;sup>&lt;i>R725X/R2156W&lt;/i>&lt;/sup> compound heterozygous mutations using CRISPR/Cas9 and showed that these mice recapitulated the human cryptophthalmos phenotype.&lt;h4>Methods&lt;/h4>In this study, we tracked changes in the metabolic profile of embryos and expression of metabolism-related genes in &lt;i>Frem2&lt;/i> mutant mice on E13.5 compared with wild-type mice. RNA sequencing (RNA-seq) was utilized to decipher the differentiated expression of genes </pubmed_abstract><journal>Frontiers in cell and developmental biology</journal><pubmed_title>The Metabolic Reprogramming of &lt;i>Frem2&lt;/i> Mutant Mice Embryos in Cryptophthalmos Development.</pubmed_title><pmcid>PMC7820765</pmcid><funding_grant_id>81770967</funding_grant_id><funding_grant_id>91546101</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Dongye M</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Lin H</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Metabolic Reprogramming of &lt;i>Frem2&lt;/i> Mutant Mice Embryos in Cryptophthalmos Development.</name><description>&lt;h4>Background&lt;/h4>Cryptophthalmos is characterized by congenital ocular dysplasia with eyelid malformation. The pathogenicity of mutations in genes encoding components of the FRAS1/FREM protein complex is well established, but the underlying pathomechanisms of this disease are still unclear. In the previous study, we generated mice carrying &lt;i>Frem2&lt;/i> &lt;sup>&lt;i>R725X/R2156W&lt;/i>&lt;/sup> compound heterozygous mutations using CRISPR/Cas9 and showed that these mice recapitulated the human cryptophthalmos phenotype.&lt;h4>Methods&lt;/h4>In this study, we tracked changes in the metabolic profile of embryos and expression of metabolism-related genes in &lt;i>Frem2&lt;/i> mutant mice on E13.5 compared with wild-type mice. RNA sequencing (RNA-seq) was utilized to decipher the differentiated expression of genes </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-05-04T23:49:33.829Z</modification><creation>2021-02-21T03:05:09Z</creation></dates><accession>S-EPMC7820765</accession><cross_references><pubmed>33490088</pubmed><doi>10.3389/fcell.2020.625492</doi></cross_references></HashMap>